August 24, 2021 By mahmoud Camrelizumab versus placebo combined with gemcitabine and cisplatin for recurrent or metastatic nasopharyngeal carcinoma: A randomized, double-blind, phase III trial. Read More
August 24, 2021 By mahmoud Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who have progressed after prior VEGFR-targeted therapy: Results from the phase 3 COSMIC-311 trial Read More
August 24, 2021 By mahmoud Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicenter, randomized controlled trial Read More
August 24, 2021 By mahmoud Neoadjuvant & adjuvant Nivolumab with anti-LAG3 antibody relatlimab for patients with resectable clinical stage III melanoma Read More
August 24, 2021 By mahmoud Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system tumors Read More
August 24, 2021 By mahmoud SPEARHEAD-1: a phase 2 trial of afamitresgene autoleucel in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma Read More
August 24, 2021 By mahmoud A phase III study (APROMISS) of AL3818 (Catequentinib, Anlotinib) hydrochloride monotherapy in subjects with metastatic or advanced synovial sarcoma Read More